The Journal of International Medical Research published a meta-analysis and Mendelian randomization (MR) evaluating the association between glucosamine supplementation and the risk for type 2 diabetes (T2D). Extremely high dose animal studies followed by one previously published human study suggested that glucosamine supplementation might exacerbate insulin resistance when used to treat osteoarthritis.
